A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country

Author:

Pinhata Juliana Maira WatanabeORCID,Ferrazoli Lucilaine,Mendes Flávia de Freitas,Gonçalves Maria Gisele,Rabello Michelle Christiane da Silva,Ghisi Kelen Teixeira,Simonsen Vera,Cavalin Roberta Figueiredo,Lindoso Ana Angélica Bulcão Portela,de Oliveira Rosângela Siqueira

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference51 articles.

1. World Health Organization (WHO). WHO global TB report 2022 [Internet]. 2022. Available at: https://www.who.int/publications/i/item/9789240061729. Accessed 10 Dec 2022

2. Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R et al (2014) Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med [Internet]. 11:e1001675. https://doi.org/10.1371/journal.pmed.1001675

3. Ministério da Saúde. Boletim Epidemiológico da Tuberculose no Brasil – Março de 2023 [Internet]. 2023. Available at : https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2023/boletim-epidemiologico-de-tuberculose-numero-especial-mar.2023/view#:~:text=N%C3%BAmero%20Especial%20%7C%20Mar.-,2023,compat%C3%ADveis%20com%20os%20problemas%20identificados. Accessed 05 Apr 2023

4. Ministério da Saúde (2022) Série histórica do número de casos novos e de incidência de tuberculose. Brasil, Regiões e Unidades Federadas de residência por ano diagnóstico (1990 a 2021). Available at: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/t/tuberculose/situacao-epidemiologica. Accessed 09 Apr 2023

5. Soini H, Musser JM (2001) Molecular diagnosis of mycobacteria. Clin Chem 47:809–14. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11325882. Accessed 08 Nov 2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3